UBSI Earnings Outperform, Targets Rise
United Bankshares (UBSI) Beats Q2 Earnings, Prompting Analysts to Raise Price Targets
Anonymous
Key Points
1
KBW raised United Bankshares' price target to $48 from $46, with the note that this target implies about a 0.27% downside from the stock’s prior close.
2
Hovde Group increased its UBSI target to $50 from $49, while maintaining a market-perform rating.
3
Analyst ratings show three Buy and four Hold for UBSI, with MarketBeat noting a Hold consensus and an average target around $47.80.
4
UBSI posted Q2 earnings of $0.95 per share, beating estimates of $0.89, with the prior-year quarter delivering $0.85.
5
The company's Q2 release occurred on Thursday, July 23.
UBS has been busy this week maintaining Neutral ratings on several stocks while nudging price targets higher. The bank raised its target on WR Berkley to $77 from $71 — an 8.45% increase — and lifted its target on Booz Allen Hamilton to $78 from $70, according to GuruFocus. RenaissanceRe Holdings also got a target bump to $349, per Benzinga.
The moves signal a pattern: UBS sees these companies as fairly valued but improving. A Neutral rating means UBS is not telling clients to buy or sell — just hold tight. Still, higher targets suggest analysts see modest room to run.
UBS Lifts WR Berkley and Booz Allen Targets
UBS raised its price target on WR Berkley (NYSE: WRB) to $77, up from $71. That is an 8.45% jump in the target, according to GuruFocus. The Neutral rating stayed in place. For Booz Allen Hamilton (NYSE: BAH), UBS analyst Gavin Parsons pushed the target to $78 from $70 on July 27, 2026. That is a $8 increase, or about 11.4%.
Both ratings stayed at Neutral. UBS is not calling these stocks screaming buys. But raising targets while holding Neutral is a soft positive signal. It means the bank thinks fair value has moved higher — even if not enough to trigger a full Buy call.
RenaissanceRe Gets a Bigger Price Target Too
UBS also maintained its Neutral rating on RenaissanceRe Holdings, raising the price target to $349, per Benzinga. RenaissanceRe is a specialty reinsurer — a company that sells insurance to other insurance companies. The higher target reflects a more optimistic view of the reinsurance market's earnings power.
The pattern across all three names is consistent. UBS is not changing its stance. It is adjusting its math. Higher targets with unchanged Neutral ratings suggest the bank sees improving fundamentals — but not enough upside to push clients to act aggressively.
United Bankshares Analysts Also Turn More Upbeat
Separately, United Bankshares (UBSI) drew a wave of positive analyst updates. Keefe, Bruyette & Woods raised its price target to $48 from $46, keeping a market-perform rating. Hovde Group lifted its target to $50 from $49. Raymond James boosted its objective to $50 and rated the stock outperform. The average analyst target sits around $47.80, with a Hold consensus.
UBSI backed up the optimism with strong numbers. The company posted Q2 earnings of $0.95 per share, beating the $0.89 estimate. Revenue came in at $323.82 million, above the $320.07 million consensus. The prior-year quarter delivered just $0.85 per share — so year-over-year growth is clear. Analysts now expect about $3.65 per share for the full year.
What a Neutral Rating Actually Means for Investors
A Neutral or market-perform rating means an analyst thinks the stock will move roughly in line with the broader market. It is not a red flag. But it is not a green light to load up either. When a bank like UBS raises a price target while keeping Neutral, it often means the stock has already priced in a lot of good news.
For UBSI, the Hold consensus across seven analysts — three Buy, four Hold — tells a similar story. The stock is in decent shape. Earnings are beating estimates. Hedge funds have been adding positions. But with the average target near $47.80 and limited upside from current levels, analysts are watching rather than chasing.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
11
Articles
9
Reach
20
A
AnonymousAuthor
